On September 2, 2007, a boy aged 10 years was evaluated in a local ED for headache, body aches, high fever, nausea, vomiting, and fainting. His symptoms had begun on August 31 with headache and lethargy. After admission to a hospital, his symptoms rapidly progressed to a fever of 104.0°F (40.0°C), confusion, and abdominal pain. Motile amebae, later identified as N. fowleri, were found in CSF on September 3--4. Amphotericin B, rifampin, azithromycin, and fluconazole were administered; however, the boy died September 4. The patient's exposure history included swimming and wakeboarding at a privately owned water sports facility on August 19 and August 26. On the latter date, the water temperature of the lake was 89.0°F (31.7°C), and the air temperature was 94.0°F (34.4°C).
Texas. In August 2007, a boy aged 12 years was admitted to a hospital with a 6-day history of fever. His mother reported her son had become disoriented and lethargic. The boy had been attending a summer camp in Central Texas in the weeks preceding his illness and had participated in recreational water activities in a lake cove. During the week before hospitalization, he visited the camp nurse three times, reporting he was "not feeling well." After admission to the hospital, analysis of the boy's CSF indicated opaque appearance, bloody color, a white blood cell count of 1,750 cells/mm 3 On August 31, 2007, a man aged 22 years was admitted to a hospital with symptoms of photosensitivity, altered mental status, and a severe headache that had begun suddenly 2 days before. The headache was frontal and described as a constant pressure sensation. A computer tomography scan of the head without contrast was interpreted as normal. The admission diagnosis was viral meningitis. Despite intensive treatment, the patient died September 4. N. fowleri was detected in postmortem brain specimens. According to acquaintances, the man had sustained a ruptured eardrum after a fall while wakeboarding in the same lake as the other Texas decedent on August 24, 7 days before admission to the hospital.
Case Review, 1937--2007
In response to the six PAM cases reported in 2007, CDC and the Council of State and Territorial Epidemiologists (CSTE) formed the Naegleria Workgroup* to review future actions related to N. fowleri and to determine whether the six cases represented an increase in the annual number of cases. The workgroup used multiple resources to conduct a review of all PAM cases reported in the United States during 1937--2007: 1) the Waterborne Disease and Outbreak Surveillance System, † which has tracked PAM cases since 1989; 2) the compressed mortality file of the National Vital Statistics System, searching on International Classification of Diseases, Ninth Revision (ICD-9) code 136.2 (specific infections by free-living amebae) and ICD-10 code B60. Exposure primarily occurred in untreated, warm, freshwater lakes or rivers in 15 southern tier states (Arizona, Arkansas, California, Florida, Georgia, Louisiana, Mississippi, Missouri, Nevada, New Mexico, North Carolina, Oklahoma, South Carolina, Texas, and Virginia); the state of exposure for four cases was unknown. Among the 112 cases for which month of exposure was known, 95 (85%) occurred during July--September. 
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Editorial Note:
Preliminary results of the review of PAM cases in the United States during 1937--2007 by the CDC/CSTE Naegleria Workgroup indicates that PAM is a rare disease that primarily affects young male users of warm recreational freshwaters, during summer months, in southern tier states. Although no estimate is available for the number of persons exposed to warm recreational freshwaters, given the increase in the U.S. population and the likelihood that more persons have been exposed over time, incidence of PAM does not appear to be increasing. Nonetheless, reports of PAM fatalities often prompt heightened public concern about the disease, and state and local health departments face challenges in assessing the risk from PAM and communicating that risk to the public.
In addition to conducting the review of PAM cases, objectives of the Naegleria Workgroup are to 1) update PAM risk-communication messages for health-care providers and the public, 2) propose making PAM a nationally notifiable disease, 3) develop a more extensive case-reporting form, and 4) review the role of environmental testing for N. fowleri. Although the workgroup continues to address these issues, this report contains its current findings and recommendations.
Because PAM is a rare disease, it does not generate a high index of suspicion among health-care providers. Symptoms of N. fowleri infection (See box, below) are clinically similar to those for bacterial or viral meningitis, further lowering the index of suspicion for PAM and initiation of appropriate diagnostic testing (1, 2, 4) . Making PAM a nationally notifiable condition might improve case detection through increased awareness, reporting, and information about cases. Such information might enable earlier detection of infections, provide insight into the human or environmental determinants of infection, and allow improved assessment of treatment effectiveness.
In the United States, N. fowleri is commonly found in warm freshwater environments in southern tier states (5--7) . The common finding of these amebae in the environment makes elimination from natural waters impractical. Because the location and number of amebae in the water can vary over time, environmental sampling, testing, and posting of warning signs are unlikely to be effective in preventing infections. In addition, warning signs posted on selected lakes might create a misconception that those bodies of water not posted with warnings are free from N. fowleri. Recreational water users should always assume a low level of risk is associated with entering all warm freshwaters in southern tier states.
The extremely low incidence of PAM makes epidemiologic study difficult; why certain persons become infected with the amebae while millions of others exposed to warm recreational freshwaters do not is unknown. Although attempts have been made to determine what concentration of N. fowleri in the environment poses an unacceptable risk, how a standard might be set to protect human health and how regulators might measure and enforce such a standard is unclear (8) .
Because a low level of risk from PAM likely exists for all users of warm freshwaters during summer to early fall, public health agencies should broadly disseminate evidence-based information on PAM in their recommendations for healthy swimming (See box, below). The only certain way to prevent N. fowleri infection is to refrain from water-related activities. However, although supporting data are absent, risk for infection might be reduced by measures that minimize water entering the nose when using warm freshwater lakes or rivers in southern tier states. Additional information on N. fowleri infection is available at http://www.cdc.gov/ncidod/dpd/parasites/naegleria.
